-

Clarification on the Two Independent Expert Reports Issued on Behalf of the Nanterre Commercial Court and Available on 23 June 2023 on the ORPEA Website

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

ORPEA (Paris:ORP):

The Company invites investors, shareholders and creditors to read the full content of the two reports made available on its website on 23 June. The fragmentary pieces of information extracted in certain press articles do not provide a fair assessment of the current value of the Company's shares.

The figures given in the Company's press release published on Friday evening are not equity values but valuations of the activities (enterprise value, i.e “Valeurs d’Entreprise” as labeled in the subject expert reports) of the ORPEA Group as a going concern and of ORPEA SA in a liquidation scenario, as described in each of the two reports.

With regard to the valuation of the ORPEA Group's as a going concern, the enterprise value, estimated by the firm Ledouble at between €6 billion and €7 billion, should be compared with the ORPEA Group's financial debt of €9.7 billion at 31 December 2022.

With regard to the valuation of ORPEA SA in a liquidation scenario, it aims to address a scenario in which the accelerated safeguard plan is not adopted, leading to the liquidation of the Company through the sale of individual assets or the sale of all of ORPEA SA's assets to a buyer. According to this approach, the enterprise value of the Company, estimated by the firm Ledouble at between €2.6 billion and €3.7 billion, should be compared with the Company ORPEA SA's financial debt of €7.4 billion at 31 December 2022.

In each of these scenarios, consequently, the economic present value of equity is negative.

This situation explains the treatment reserved for shareholders in the Company's accelerated safeguard plan. Under the terms of the plan, existing shareholders will be massively diluted by the entry into the capital of unsecured creditors and new investors. As reminded in the press release of 26 May 2023 and its appendices, the capital increases provided for in the safeguard plan will be carried out at prices ranging from €0.607 to €0.013 per new share depending on the scenarios.

These two reports are available on the ORPEA website in the "Restructuring" section [link]

About ORPEA

ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 21 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year.

https://www.orpea-group.com/en

ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120 and CAC Mid 60 indices.

Contacts

Investor Relations
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Toll-free number for shareholders:
0 805 480 480

Investor Relations
NewCap
Dusan Oresansky
Tel.: 01 44 71 94 94
ORPEA@newcap.eu

Press Relations
ORPEA
Isabelle Herrier-Naufle
Press Relations Director
Tel.: 07 70 29 53 74
i.herrier-naufle@orpea.net

Image7
Charlotte Le Barbier // Laurence Heilbronn
06 78 37 27 60 - 06 89 87 61 37
clebarbier@image7.fr
lheilbronn@image7.fr

ORPEA

BOURSE:ORP

Release Versions

Contacts

Investor Relations
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Toll-free number for shareholders:
0 805 480 480

Investor Relations
NewCap
Dusan Oresansky
Tel.: 01 44 71 94 94
ORPEA@newcap.eu

Press Relations
ORPEA
Isabelle Herrier-Naufle
Press Relations Director
Tel.: 07 70 29 53 74
i.herrier-naufle@orpea.net

Image7
Charlotte Le Barbier // Laurence Heilbronn
06 78 37 27 60 - 06 89 87 61 37
clebarbier@image7.fr
lheilbronn@image7.fr

More News From ORPEA

emeis Announces the Creation of Isemia, a Real Estate Company Dedicated to Healthcare Real Estate in Europe

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: In accordance with the agreements signed and announced on September 23, 2025, emeis (Paris:EMEIS) announces the creation of Isemia, its healthcare real estate company dedicated to healthcare real estate assets operated by the Group, with its partners Farallon Capital and TwentyTwo Real Estate. emeis has thus received €761 million from its partners, representing 62% of the last appraised value1 of the assets held by this vehicle, thereby immedia...

emeis: Half-Year Review (H2 2025) of the Liquidity Agreement Entered Into with Natixis Oddo BHF

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Under the liquidity agreement entrusted by emeis (Paris:EMEIS) (the “Company”) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as of 31 December 2025. - 70,965 shares - €1,111,687 in cash During the 2025 second half-year, it was carried out a total of: PURCHASE 1,513 transactions 1,158,608 shares €15,241,520.04 SALE 1,604 transactions 1,165,917 shares €15,456,925.47 It is reminded that as of the las...

emeis Raises €3.15 Billion in New Financing

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) finalized the raising of new financing totaling €3.15 billion with its banking partners and financial investors, based on the agreements in principle announced in a press release on November 10, 2025. A total of €3.15 billion in new financing with an average maturity of 5.5 years and an average margin on EURIBOR of 247 basis points2. This new financing breaks down as follows: €2.2 billion in term loans (Tranche 1) with a mat...
Back to Newsroom